TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18792703

Group type: EXPERIMENTAL
Intervention: Ormocer-based composite (Admira)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Nanohybrid resin composite (Tetric EvoCeram)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Nanofill resin composite (Filtek Supreme)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Microhybrid resin composite (Tetric Ceram)
Number of subjects: 35
Study: 15695836

Group type: EXPERIMENTAL
Intervention: Antimicrobial drain sponge dressing (polyhexamethylene biguanide)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Non-impregnated, nonwoven drain sponge dressing
Number of subjects: 10
Study: 14508230

Group type: EXPERIMENTAL
Intervention: Bisoprolol 10 mg once daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Losartan 50 mg once daily
Number of subjects: 24
Study: 11155731

Group type: EXPERIMENTAL
Intervention: 7 day treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 14 day treatment
Number of subjects: 0
Study: 8684102

Group type: EXPERIMENTAL
Intervention: Atovaquone 1000 mg daily and proguanil 400 mg daily for 3 days
Number of subjects: 142

Group type: COMPARATOR
Intervention: Amodiaquine 600 mg on admission, 600 mg 24 h later, and 300 mg after a further 24 h
Number of subjects: 142
Study: 14621737

Group type: EXPERIMENTAL
Intervention: Oral nifedipine (group B)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Low-dose CyA plus azathioprine (group C)
Number of subjects: 68
Study: 3970747

Group type: EXPERIMENTAL
Intervention: Antibiotics (penicillinase-resistant penicillin or erythromycin)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Penicillinase-resistant antibiotic
Number of subjects: 33
Study: 31595289

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program (two sessions per week of individualized and progressive strength and balance exercises for 3 months)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Dual-task training group (simultaneous cognitive tasks with the same physical tasks as the multicomponent group for 3 months)
Number of subjects: 85
Study: 29766470

Group type: EXPERIMENTAL
Intervention: Mothers and Babies (MB) 1‐on‐1 intervention delivered by trained home visitors
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual home visiting
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Mothers and Babies (MB) 1‐on‐1 intervention
Number of subjects: 120
Study: 26402571

Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Diet (LC)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control Diet (CON)
Number of subjects: 24
Study: 25863559

Group type: EXPERIMENTAL
Intervention: Ledipasvir (90 mg) and sofosbuvir (400 mg)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Ledipasvir (90 mg) and sofosbuvir (400 mg) plus ribavirin
Number of subjects: 341
Study: 22365595

Group type: EXPERIMENTAL
Intervention: Class II below knee elastic stockings (ESs, Medi UK Ltd.), fitted immediately and worn until pain-free and fully mobile.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Tubigrip, fitted immediately and worn until pain-free and fully mobile.
Number of subjects: 36
Study: 20047800

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy (62 Gy/20 fractions/5 weeks, 4 fractions per week)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Conventional fractionation radiotherapy (80 Gy/40 fractions/8 weeks)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy
Number of subjects: 168

Group type: COMPARATOR
Intervention: Conventional fractionation radiotherapy
Number of subjects: 168
Study: 19040034

Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted influenza subunit vaccine (FLUAD)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Conventional non-adjuvanted influenza subunit vaccine (Agrippal)
Number of subjects: 600
Study: 15981669

Group type: EXPERIMENTAL
Intervention: Whole PTH assay
Number of subjects: 25
Study: 12589351

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (220 microg/d)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 10475285

Group type: EXPERIMENTAL
Intervention: Amiodarone (3.4 g over 5 days or 2.2 g over 24 hours)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 8904945

Group type: EXPERIMENTAL
Intervention: Reinforcement and consumer-demand theory strategies for reducing cocaine use
Number of subjects: 0
Study: 2065685

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 10

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 10
Study: 6152563

Group type: EXPERIMENTAL
Intervention: zopiclone 7.5 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: flunitrazepam 1 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: triazolam 0.25 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: lormetazepam 1 mg
Number of subjects: 10
Study: 30686385

Group type: EXPERIMENTAL
Intervention: THPP and Enhanced Usual Care (EUC)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC) only
Number of subjects: 280
Study: 29790581

Group type: EXPERIMENTAL
Intervention: PUR0200 3 μg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PUR0200 6 μg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PUR0200 9 μg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tiotropium HH 18 μg
Number of subjects: 0
Study: 27401316

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol (FF/VI) 100/25 μg
Number of subjects: 307

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 307
Study: 25201572

Group type: EXPERIMENTAL
Intervention: Integrated neonatal kit delivery and education on usage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current standard of care
Number of subjects: 0
Study: 18977094

Group type: EXPERIMENTAL
Intervention: WBRT+MGd
Number of subjects: 554

Group type: COMPARATOR
Intervention: WBRT
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: WBRT+MGd (North American patients)
Number of subjects: 554
Study: 16382755

Group type: EXPERIMENTAL
Intervention: Neoangelac Plus with AA and DHA supplementation
Number of subjects: 27

Group type: COMPARATOR
Intervention: Neoangelac without AA and DHA supplementation
Number of subjects: 27
Study: 12146537

Group type: EXPERIMENTAL
Intervention: Powered toothbrush (PB)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Manual toothbrush (M)
Number of subjects: 157
Study: 9160382

Group type: EXPERIMENTAL
Intervention: Early amniocentesis (EA)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Chorionic villus sampling (CVS)
Number of subjects: 321
Study: 8187256

Group type: EXPERIMENTAL
Intervention: Oral midazolam 0.5 mg.kg‐1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Oral ketamine 5.0 mg.kg‐1
Number of subjects: 40
Study: 2978036

Group type: EXPERIMENTAL
Intervention: PTFE‐Y graft
Number of subjects: 112

Group type: COMPARATOR
Intervention: Dacron‐Y graft
Number of subjects: 112
Study: 989091

Group type: EXPERIMENTAL
Intervention: Continuous intravenous heparin sodium therapy
Number of subjects: 41

Group type: COMPARATOR
Intervention: Intermittent (four‐hourly bolus) heparin therapy
Number of subjects: 41
Study: 30659666

Group type: EXPERIMENTAL
Intervention: Triclosan/fluoride toothpaste (n:13)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Fluoride toothpaste (n:13)
Number of subjects: 26
Study: 29283470

Group type: EXPERIMENTAL
Intervention: REMD‐477 (70 mg dose)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 27331913

Group type: EXPERIMENTAL
Intervention: Caffeine-polyphenol supplement
Number of subjects: 12
Study: 24269575

Group type: EXPERIMENTAL
Intervention: Duloxetine (combined serotonin-norepinephrine reuptake inhibitor)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 22266163

Group type: EXPERIMENTAL
Intervention: Caffeine (single oral dose)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 21061756

Group type: EXPERIMENTAL
Intervention: Methylaminolevulinate (MAL) 80 mg/g without occlusion followed by 25 J/cm2 red light exposure
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Methylaminolevulinate (MAL) 80 mg/g with occlusion followed by 25 J/cm2 red light exposure
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Methylaminolevulinate (MAL) 80 mg/g without occlusion followed by 37 J/cm2 red light exposure
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Methylaminolevulinate (MAL) 80 mg/g with occlusion followed by 37 J/cm2 red light exposure
Number of subjects: 44
Study: 17426414

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 129

Group type: COMPARATOR
Intervention: Antidepressant treatment (paroxetine or clomipramine)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 15365215

Group type: EXPERIMENTAL
Intervention: m-chlorophenylpiperazine (mCPP)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: sumatriptan
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study: 11394676

Group type: EXPERIMENTAL
Intervention: Primed test items
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unprimed test items
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Item and associative recognition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plurality and associative recognition
Number of subjects: 0
Study: 9580313

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 0.9 MU of rIL‐2 subcutaneously administered daily for 8 weeks
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 1.8 MU of rIL‐2 subcutaneously administered daily for 8 weeks
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 3.6 MU of rIL‐2 subcutaneously administered daily for 8 weeks
Number of subjects: 31
Study: 7850601

Group type: EXPERIMENTAL
Intervention: Children with a history of abuse
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nonmaltreated children
Number of subjects: 45
Study: 3182542

Group type: EXPERIMENTAL
Intervention: Calcium phosphate (176 mmol/day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31836545

Group type: EXPERIMENTAL
Intervention: Guided slow-paced respiration intervention using a portable biofeedback device (RESPeRATE) for 12 weeks, N=79
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control group using an identical device programmed to play nonrhythmic music for 12 weeks, N=82
Number of subjects: 161
Study: 29999436

Group type: EXPERIMENTAL
Intervention: PAA + RFA
Number of subjects: 94

Group type: COMPARATOR
Intervention: RFA
Number of subjects: 94
Study: 27426936

Group type: EXPERIMENTAL
Intervention: Short-term DAPT (≤6 months)
Number of subjects: 11473

Group type: COMPARATOR
Intervention: Long-term DAPT (≥1 year)
Number of subjects: 11473
Study: 26630576

Group type: EXPERIMENTAL
Intervention: Doxorubicin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Baseline mutant tumors (n = 10; PIK3CA mutations n = 8)
Number of subjects: 40
Study: 23537017

Group type: EXPERIMENTAL
Intervention: Vitamin C (1000 mg total)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (sucrose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control arm (no intervention)
Number of subjects: 12
Study: 21356018

Group type: EXPERIMENTAL
Intervention: Toothbrush T1 - bristles on the same plane, straight arrangement
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Toothbrush T2 - bristles on different planes, straight arrangement
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Toothbrush T3 - bristles on different planes, straight and circular arrangement
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: All toothbrush models
Number of subjects: 27
Study: 18281352

Group type: EXPERIMENTAL
Intervention: Cumulative weekly breastfeeding duration by 13 weeks
Number of subjects: 255

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 255
Study: 16781249

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sedentary lifestyle (control)
Number of subjects: 12
Study: 15271868

Group type: EXPERIMENTAL
Intervention: Half-dose triptorelin (1.87 mg)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Full-dose triptorelin (3.75 mg)
Number of subjects: 180
Study: 10858349

Group type: EXPERIMENTAL
Intervention: Itraconazole oral solution (2.5 mg/kg twice a day)
Number of subjects: 557

Group type: COMPARATOR
Intervention: Amphotericin B capsules (500 mg orally four times a day)
Number of subjects: 557
Study: 9089968

Group type: EXPERIMENTAL
Intervention: VATS lobectomy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard lobectomy (control group)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (standard lobectomy)
Number of subjects: 70
Study: 8456902

Group type: EXPERIMENTAL
Intervention: Fish oil (2.7 gm of n‐3 fatty acid per day)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (olive oil or no oil supplementation)
Number of subjects: 47
Study: 3510762

Group type: EXPERIMENTAL
Intervention: Dipyridamole plus aspirin
Number of subjects: 407

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 407
Study: 31012225

Group type: EXPERIMENTAL
Intervention: iVAPS AutoEPAP
Number of subjects: 38

Group type: COMPARATOR
Intervention: iVAPS manual EPAP
Number of subjects: 38
Study: 30222861

Group type: EXPERIMENTAL
Intervention: Applied Muscle Tension (AMT) at strategic time points (n = 250)
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: Applied Muscle Tension (AMT) during entire donation (n = 244)
Number of subjects: 734

Group type: COMPARATOR
Intervention: Standard blood donation control (n = 240)
Number of subjects: 734
Study: 26891646

Group type: EXPERIMENTAL
Intervention: Scapular stabilization exercise (SSE)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (relaxed by lying supine quietly)
Number of subjects: 36
Study: 24792708

Group type: EXPERIMENTAL
Intervention: Multisensory stimulation in a multisensory stimulation environment (MSSE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: One-to-one activity sessions
Number of subjects: 0
Study: 23129085

Group type: EXPERIMENTAL
Intervention: Short behavioral counseling intervention on strategies to decrease screen time
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 20142307

Group type: EXPERIMENTAL
Intervention: Sleep deprivation alone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Morphine alone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Combination of sleep deprivation and morphine
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Buprenorphine on dosing day with sleep deprivation
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Alternate-day buprenorphine dosing
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 19
Study: 18664888

Group type: EXPERIMENTAL
Intervention: Psychosocial treatments for PTSD
Number of subjects: 239668

Group type: EXPERIMENTAL
Intervention: Psychosocial treatments for PTSD targeting combat-related trauma
Number of subjects: 239668
Study: 16599101

Group type: EXPERIMENTAL
Intervention: Zinc sulphate tablet (20 mg)
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1600

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 1600
Study: 12166540

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol 160/4.5 microg, two inhalations twice daily (n=390)
Number of subjects: 586

Group type: COMPARATOR
Intervention: Budesonide plus formoterol administered via separate inhalers (n=190)
Number of subjects: 586
Study: 10604851

Group type: EXPERIMENTAL
Intervention: Oxygen administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Air inhalation (control)
Number of subjects: 0
Study: 7546830

Group type: EXPERIMENTAL
Intervention: Clodronate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other bisphosphonates
Number of subjects: 0
Study: 1714669

Group type: EXPERIMENTAL
Intervention: Bonnecor (2 x 0.1 to 1 x 0.3 mg/kg body weight)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Bonnecor
Number of subjects: 68

Group type: COMPARATOR
Intervention: Verapamil retard
Number of subjects: 68
Study: 377449

Group type: EXPERIMENTAL
Intervention: Choline magnesium trisalicylate (CMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ACSA)
Number of subjects: 0
Study: 30128855

Group type: EXPERIMENTAL
Intervention: Qigong intervention
Number of subjects: 50

Group type: COMPARATOR
Intervention: Gentle exercise
Number of subjects: 50

Group type: COMPARATOR
Intervention: Survivorship support
Number of subjects: 50
Study: 27918733

Group type: EXPERIMENTAL
Intervention: Basic information given verbally with details of operative procedures and recovery, and by watching a movie on single implant surgery (movie group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Basic information given verbally, with details of operation and recovery (group 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Basic information given verbally but devoid of details of the operative procedures and recovery (control group)
Number of subjects: 60
Study: 25399033

Group type: EXPERIMENTAL
Intervention: HIV/STI intervention
Number of subjects: 848

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 848
Study: 23958023

Group type: EXPERIMENTAL
Intervention: Fish oil (FO) supplement (200 g/d)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Microalgae (MA) supplement (200 g/d)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (no marine oil supplement)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Pasture management system (PAS)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Confinement management system (CONF)
Number of subjects: 48
Study: 21350032

Group type: EXPERIMENTAL
Intervention: Abbreviated version of GMFM-66 (item set approach)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Abbreviated version of GMFM-66 (basal and ceiling approach)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Full GMFM-66
Number of subjects: 26
Study: 19116800

Group type: EXPERIMENTAL
Intervention: Insomnia treatment study volunteers (n = 120)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Clinical patients seeking treatment (n = 106)
Number of subjects: 226
Study: 17263835

Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg once-daily (n = 122)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Ciprofloxacin 500 mg twice-daily plus phenethicillin 250 mg four-times-daily (n = 120)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 242

Group type: COMPARATOR
Intervention: Ciprofloxacin plus phenethicillin
Number of subjects: 242
Study: 15269617

Group type: EXPERIMENTAL
Intervention: Locally produced RTUF
Number of subjects: 260

Group type: COMPARATOR
Intervention: Imported RTUF
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 260
Study: 11736723

Group type: EXPERIMENTAL
Intervention: Pantoprazole
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 9418709

Group type: EXPERIMENTAL
Intervention: Esterified estrogens
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Esterified estrogen + methyltestosterone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 8500785

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg metoclopramide
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg metoclopramide
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.4 mg/kg metoclopramide
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 3425810

Group type: EXPERIMENTAL
Intervention: Postoperative nasogastric decompression
Number of subjects: 56

Group type: COMPARATOR
Intervention: No postoperative nasogastric decompression
Number of subjects: 56
Study: 2553879

Group type: EXPERIMENTAL
Intervention: First-line MVP (mitomycin, vinblastine, and cisplatin)
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: VP (vinblastine and cisplatin)
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: MVP/CAMP (mitomycin, vinblastine, cisplatin alternating with cyclophosphamide, doxorubicin, methotrexate, and procarbazine)
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Carboplatin
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Iproplatin
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Second-line MVP
Number of subjects: 699

Group type: COMPARATOR
Intervention: Combination regimens
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Initial treatment with MVP
Number of subjects: 699
Study: 31550354

Group type: EXPERIMENTAL
Intervention: High-dose (HD) trivalent inactivated vaccine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard-dose (SD) trivalent inactivated vaccine
Number of subjects: 60
Study: 31080008

Group type: EXPERIMENTAL
Intervention: Single Needle Celiac Neurolysis
Number of subjects: 34

Group type: COMPARATOR
Intervention: Double Needles Celiac Neurolysis
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 34
Study: 27429029

Group type: EXPERIMENTAL
Intervention: Pasireotide (n = 152)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo (n = 148)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Overall (n = 300)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Patients with POPF (n = 45)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Patients without POPF (n = 255)
Number of subjects: 300
Study: 24474721

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided foamsclerotherapy
Number of subjects: 225
Study: 23126307

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg/day
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Aspirin initiated before 16 weeks of gestation (from meta-analysis)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 21739068

Group type: EXPERIMENTAL
Intervention: Dietary intervention with additional support (metabolic syndrome manual book, telephone counseling, nutrition education leaflets)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group following the same diet without additional support
Number of subjects: 0
Study: 19427269

Group type: EXPERIMENTAL
Intervention: High-dose ascorbic acid (about 30 mg/kg/day)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81